Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc.
Public
Traded as NASDAQ: TNDM
Founded San Diego, California 2006 (2006)
Headquarters San Diego, California, United States
Number of employees
 437
Website www.tandemdiabetes.com

Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.[1]

History

In 2006, a group of engineers recognized the need for new and improved methods of pumping insulin and incorporated as Phluid, Inc.[2] In 2007, Kim Blickenstaff joined the organization as President and CEO, bringing his philosophy of using market research as the inspiration for product development and started on the development of the t:slim Insulin Pump.[3] In 2008, this predecessor company became the newly incorporated Tandem Diabetes Care, Inc. that was formed with a focus on promoting a comprehensive, user-centric, and integrated approach to diabetes product development and customer care.[4] Tandem Diabetes Care felt that incorporating enhanced ease of use and attractive design—often associated with consumer electronics development—would also encourage more patients to consider the clinical benefits of insulin pump therapy. Tandem Diabetes Care interviewed more than 4,000 insulin pump users and health care providers to design its first device, the t:slim Insulin Pump.[5]

Products

In November 2011, the company received FDA clearance to market the t:slim Insulin Pump, the first ever touch-screen insulin pump.[6] In February 2013, the company received FDA clearance to market the t:connect Diabetes Management Application, a Mac and PC-compatible data management application that provides t:slim Pump users and their healthcare providers a way to display data from the pump and supported blood glucose meters on a cloud-based platform.[7] In January 2015, Tandem announced FDA clearance of the t:flex Insulin Pump, the largest capacity insulin pump on the market.[8] In July 2014, Tandem announced that it had submitted a PMA for the t:slim G4, which integrates t:slim Pump technology with the Dexcom G4 Platinum CGM System. This device was approved by the FDA in September 2015.[9]

References

  1. ↑ http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=46368713
  2. ↑ http://www.bloomberg.com/research/stocks/snapshot/snapshot_article.asp?ticker=TNDM
  3. ↑ http://www.sandiegouniontribune.com/news/2011/nov/16/san-diegos-tandem-diabetics-sell-compact-insulin-p/
  4. ↑ http://www.tandemdiabetes.com/News/2013/Tandem-Diabetes-Care-Wins-MDEA-Readers--Choice-Award-for-t-slim-Pump/
  5. ↑ http://diatribe.org/companiesorganization/tandem-diabetes-care
  6. ↑ http://www.medgadget.com/2011/11/tandem-tslim-glucose-pump-gets-fda-clearance.html
  7. ↑ http://www.healthline.com/diabetesmine/tandem-tslim-pumpers-now-connected
  8. ↑ http://www.healthline.com/diabetesmine/newsflash-fda-clears-expanded-cartridge-tflex-insulin-pump
  9. ↑ http://www.medscape.com/viewarticle/850821


This article is issued from Wikipedia - version of the Tuesday, January 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.